Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment
- PMID: 21922339
- DOI: 10.1007/s00296-011-2130-5
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment
Abstract
A patient with chronic inflammatory demyelinating polyradiculoneuropathy and systemic lupus erythematosus arising after rubella vaccination was initially treated with plasmapheresis, corticosteroids and intravenous immunoglobulins, with partial response. After shift to rituximab, most clinical symptoms improved markedly, emphasizing the possible role of this monoclonal antibody in conventional therapy-resistant cases.
Similar articles
-
Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.Lupus. 2012 Sep;21(10):1119-23. doi: 10.1177/0961203312440346. Epub 2012 Mar 20. Lupus. 2012. PMID: 22433918 Review.
-
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity.Lupus. 2023 Aug;32(9):1123-1125. doi: 10.1177/09612033231186718. Epub 2023 Jun 27. Lupus. 2023. PMID: 37369195
-
Chronic inflammatory demyelinating polyneuropathy associated with active systemic lupus erythematous: Anifrolumab as a potentially successful add-on therapy to intravenous immunoglobulins.Lupus. 2025 Mar;34(3):312-315. doi: 10.1177/09612033251314610. Epub 2025 Jan 17. Lupus. 2025. PMID: 39819214
-
The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.Clin Rheumatol. 2012 Feb;31(2):381-4. doi: 10.1007/s10067-011-1878-z. Epub 2011 Oct 21. Clin Rheumatol. 2012. PMID: 22015937 Review.
-
Current and novel therapeutics in the treatment of systemic lupus erythematosus.J Allergy Clin Immunol. 2011 Feb;127(2):303-12; quiz 313-4. doi: 10.1016/j.jaci.2010.12.1087. J Allergy Clin Immunol. 2011. PMID: 21281862 Free PMC article. Review.
Cited by
-
Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management.Front Immunol. 2022 Jul 4;13:890142. doi: 10.3389/fimmu.2022.890142. eCollection 2022. Front Immunol. 2022. PMID: 35860284 Free PMC article. Review.
-
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Cochrane Database Syst Rev. 2017 May 8;5(5):CD003280. doi: 10.1002/14651858.CD003280.pub5. Cochrane Database Syst Rev. 2017. PMID: 28481421 Free PMC article.
-
Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.Semin Neurol. 2012 Jul;32(3):187-95. doi: 10.1055/s-0032-1329194. Epub 2012 Nov 1. Semin Neurol. 2012. PMID: 23117943 Free PMC article. Review.
-
Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature.J Clin Case Rep. 2017;7(10):1033. doi: 10.4172/2165-7920.10001033. Epub 2017 Oct 27. J Clin Case Rep. 2017. PMID: 29888753 Free PMC article.
-
Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases.J Neurol. 2017 May;264(5):1011-1014. doi: 10.1007/s00415-017-8462-7. Epub 2017 Mar 23. J Neurol. 2017. PMID: 28337614 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical